Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr:148:103-10.
doi: 10.1016/j.jsbmb.2015.01.009. Epub 2015 Jan 15.

The effect of 1,25 dihydroxyvitamin D3 treatment on the mRNA levels of β catenin target genes in mice with colonic inactivation of both APC alleles

Affiliations
Review

The effect of 1,25 dihydroxyvitamin D3 treatment on the mRNA levels of β catenin target genes in mice with colonic inactivation of both APC alleles

Marsha DeWitt et al. J Steroid Biochem Mol Biol. 2015 Apr.

Abstract

In colon cancer, adenomatous polyposis coli (APC) inactivating gene mutations increase nuclear β-catenin levels and stimulate proliferation. In vitro, 1,25 dihydroxyvitamin D (1,25(OH)2D), suppresses β-catenin-mediated gene transcription by inducing vitamin D receptor (VDR)-β-catenin interactions. We examined whether acute treatment with 1,25(OH)2D could suppress β-catenin-mediated gene transcription in the hyperplastic colonic lesions of mice with colon-specific deletion of both APC gene alleles (CAC; APC(Δ580/Δ580)). At four weeks of age, CAC; APC(Δ580/Δ580) and control mice were injected with vehicle or 1,25(OH)2D (1μg/kg body weight) once a day for three days and then killed six hours after the last injection. mRNA levels of β-catenin target genes were elevated in the colon of CAC; APC(Δ580/Δ580) mice. 1,25(OH)2D increased 25 hydroxyvitamin D-24 hydroxylase mRNA levels in the colon of CAC; APC(Δ580/Δ580) and control mice indicating the treatments activated the VDR. However, 1,25(OH)2D had no effect on either β-catenin target gene mRNA levels or the proliferation index in CAC; APC(Δ580/Δ580) or control mice. VDR mRNA and protein levels were lower (-65% and -90%) in the colon of CAC; APC(Δ580/Δ580) mice compared to control mice, suggesting loss of colon responsiveness to vitamin D. Consistent with this, vitamin D-induced expression of transient receptor potential cation channel, subfamily V, member 6 mRNA was reduced in the colon of CAC; APC(Δ580/Δ580) mice. Our data show that short term exposure to 1,25(OH)2D does not suppress colonic β-catenin signaling in vivo. This article is part of a special issue entitled '17th Vitamin D Workshop'.

Keywords: Cancer; Gene expression; Hyperplasia; Vitamin D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
1,25(OH)2D decreases mRNA levels for β-catenin target genes in Caco-2 and SW480-ADH cells. Proliferating Caco-2 and SW480-ADH cells were treated with 100 nM 1,25(OH)2D for 24 h. RNA was isolated and analyzed by RT-PCR. Gene expression was normalized to RPLP0 expression. Bars = mean ± SEM (n=3) (A) CYP24A1 mRNA. * Significantly different than EtOH treatment (p≤0.05). (B) β-catenin target gene mRNA levels. Bars represent the fold-change in expression following 1,25(OH)2D treatment. * Significantly reduced by vitamin D treatment (p<0.05).
Fig. 2
Fig. 2
Impact of 1,25(OH)2 D treatment on body weight and β-catenin gene targets in CAC; APCΔ580/Δ580 mice. Four week old mice were given three daily injections with vehicle or 1,25(OH)2 D (1 μg/kg body weight) and killed 6 h after the final injection. Bars = mean ± SEM (A) Body weight (n= 6-15 mice/group). * = p<0.05 vs vehicle treated wild-type mice. (B) β-catenin target gene mRNA levels in the distal colon of CAC; APCΔ580/Δ580 mice. (n=12-15/group). * p < 0.05 vs control mice.
Fig 3
Fig 3
Impact of 1,25(OH)2 D treatment on serum 1,25(OH)2 D and colonic expression of vitamin D target genes in CAC; APCΔ580/Δ580 mice. Four week old mice were given three daily injections with vehicle or 1,25(OH)2 D (1 μg/kg body weight) and killed six h after the final injection. Data are expressed as mean ± SEM. Values with different letter superscripts are significantly different from one another (p < 0.05, Tukey's HSD) (A) Serum 1,25(OH)2D. (n = 10/group). (B) CYP24A1 mRNA and (C) TRPV6 mRNA (n=14-20 mice/group).
Fig. 4
Fig. 4
Impact of 1,25(OH)2 D treatment on β-catenin gene targets and cellular proliferation in CAC; APCΔ580/Δ580 mice. Four week old mice were given three daily injections with vehicle or 1,25(OH)2 D (1 μg/kg body weight) and killed 6 h after the final injection. RNA was isolated from the distal colonic mucosa of CAC; APCΔ580/Δ580 mice and RT-PCR was used to measure β-catenin gene targets. Data are expressed as mean ± SEM (n=14 mice/group).
Fig. 5
Fig. 5
VDR mRNA and protein expression in colonic lesions from CAC; APCΔ580/Δ580 or CAC; APCΔ580/WT mice. (A, B) Four week old CAC; APCΔ580/Δ580 mice were given three daily injections with vehicle or 1,25(OH)2 D (1 μg/kg body weight) and killed six h after the final injection. RNA was isolated from the distal colonic mucosa and RT-PCR was used to measure VDR mRNA (A). Data are expressed as mean ± SEM (n=5-20 mice/group). Values with different letter superscripts are significantly different from one another (p≤0.05, Tukey's HSD). (B) Whole protein extracts from colon were prepared and pooled. Western blot analysis was conducted for VDR protein levels. β-actin was used as a loading control. (Veh = vehicle; 1,25D = 1,25(OH)2D) (C) Tumors from the distal colon of 20 wk-old CAC; APCΔ580/WT mice were saved and RNA was isolated and analyzed by RT-PCR for VDR mRNA levels. Bars represent the mean + SEM (n = 24/group), * Significantly different from normal mucosa of wild-type mice (p<0.05).

Similar articles

Cited by

References

    1. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence. Int J Cancer. 2009;125(1):171–180. - PubMed
    1. Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002;296(5568):695–698. - PubMed
    1. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004;13(9):1502–1508. - PubMed
    1. Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, Albanes D. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control. 1997;8(4):615–625. - PubMed
    1. Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJB, Norat T, Pischon T, Jansen EHJM, Slimani N, Byrnes G, Rinaldi S, Tjonneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Misirli G, Trichopoulos D, Berrino F, Vineis P, Panico S, Palli D, Tumino R, Ros MM, van Gils CH, Peeters PH, Brustad M, Lund E, Tormo MJ, Ardanaz E, Rodriguez L, Sanchez MJ, Dorronsoro M, Gonzalez CA, Hallmans G, Palmqvist R, Roddam A, Key TJ, Khaw KT, Autier P, Hainaut P, Riboli E. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ. 2010;340(jan21_3):b5500. - PMC - PubMed

Publication types

MeSH terms